← Back to MPLT

MapLight Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 04/12/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 04/12/2025Jun 2024Filed 04/12/2025Mar 2024Filed 04/12/2025
−$60−$61−$29−$30−$22−$19−$18−$19
−$1.32−$1.34−$37.18−$39.11−$29.33−$25.08
45450.80.80.8

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.